Less invasive surgery shows promise for anal cancer in HIV patients
NCT ID NCT02437851
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether removing small, early-stage anal cancers with local surgery alone is safe and effective for people with HIV. The goal was to see if this less invasive approach could avoid the need for stronger treatments like radiation or chemotherapy. Sixteen participants were followed for up to three years to check if the cancer came back or spread.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Grady Health System
Atlanta, Georgia, 30303, United States
-
Laser Surgery Care
New York, New York, 10011, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
University of California, San Francisco
San Francisco, California, 94115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immunotherapy drug boost the power of chemoradiation against anal cancer?
- Can a new strategy break the cycle of HIV care dropout?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Smart pill bottles and health coaches team up to tackle HIV in the deep south
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?